← Leaderboards
Hanrui Zhang
Columbia University Health Sciences
$6,712,556
Attributed
$8,264,233
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2016–25$2.5M$1.9M$1.3M$625K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,264,233 · 6
By mechanism
R01$5,312,416 · 2
P01$1,260,701 · 1
R00$732,942 · 1
R35$686,640 · 1
K99$271,534 · 1
Top collaborators
- Wei Li3 shared
- Edoardo Marcora3 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Alan Richard Tall$42,229,886
- Ira A Tabas$44,847,082
- Muredach P Reilly$136,077,018
- Stavroula Kousteni$21,735,971
- Rebecca Anne Haeusler$13,433,987
Others in their field
Top investigators on “Macrophage”
- Craig B Thompson · Sloan-Kettering Inst Can Research$41,669,179
- Howard Eliot Gendelman · Children'S Memorial Hospital (Chicago)$41,668,744
- Selwyn M Vickers · University Of Alabama At Birmingham$40,969,055
- Alan A Aderem · University Of Washington$38,969,733
- Alan Richard Tall · Columbia University Health Sciences$38,053,695
- John S Condeelis · Yeshiva University$33,855,255
Research focus
MacrophageGenesAtherosclerosisPhenotypeInduced Pluripotent Stem CellOverexpressionClustered Regularly Interspaced Short Palindromic RepeatsMediatingLipidsArterial Fatty StreakInflammationIn VivoMouse ModelInsightCrispr ScreenKnock-OutPhagocytesCellsMonocyteApoptoticKnock-InAccelerationCoronary ArteriosclerosisTherapeutic Target
Grant awards (16)
Integrative genomic and functional genomic studies to connect variant to function for CAD GWAS loci$770,223
R01 · FY2025 · HL · contact PI
Finding and pushing the limits of macrophage efferocytosis in atherosclerosis$686,640
R35 · FY2025 · HL · contact PI
Harnessing molecular breaks on macrophage efferocytosis in atherosclerosis$628,495
P01 · FY2025 · HL · contact PI
Integrative genomic and functional genomic studies to connect variant to function for CAD GWAS loci$754,819
R01 · FY2024 · HL · contact PI
Harnessing molecular breaks on macrophage efferocytosis in atherosclerosis$632,206
P01 · FY2024 · HL · contact PI
Discovering Wdfy3 as a novel regulator of macrophage efferocytosis by genome-wide CRISPR screen$579,734
R01 · FY2024 · HL · contact PI
Integrative genomic and functional genomic studies to connect variant to function for CAD GWAS loci$802,473
R01 · FY2023 · HL · contact PI
Discovering Wdfy3 as a novel regulator of macrophage efferocytosis by genome-wide CRISPR screen$593,509
R01 · FY2023 · HL · contact PI
Discovering Wdfy3 as a novel regulator of macrophage efferocytosis by genome-wide CRISPR screen$593,509
R01 · FY2022 · HL · contact PI
Discovering Wdfy3 as a novel regulator of macrophage efferocytosis by genome-wide CRISPR screen$609,009
R01 · FY2021 · HL · contact PI
Discovering Wdfy3 as a novel regulator of macrophage efferocytosis by genome-wide CRISPR screen$609,140
R01 · FY2020 · HL · contact PI
Macrophage-specific function of GWAS CAD-associated LIPA alleles in atherosclerosis$239,586
R00 · FY2020 · HL · contact PI
Macrophage-specific function of GWAS CAD-associated LIPA alleles in atherosclerosis$244,368
R00 · FY2019 · HL · contact PI
Macrophage-specific function of GWAS CAD-associated LIPA alleles in atherosclerosis$248,988
R00 · FY2018 · HL · contact PI
Macrophage-specific function of GWAS CAD-associated LIPA alleles in atherosclerosis$166,212
K99 · FY2017 · HL · contact PI
Macrophage-specific function of GWAS CAD-associated LIPA alleles in atherosclerosis$105,322
K99 · FY2016 · HL · contact PI